Key Market Indicator:
In this news category you will find information from and about companies, organizations, institutions, products of all kinds and in a broad spectrum. To get a quick overview of current trends and developments, it's worth visiting daily.
Wed, 05.02.2025
Bechtle AG
Bechtle announces preliminary figures for FY 2024
Business volume climbs by approximately 2% to around €8 bn
EBT margin at 5.5%
Key financial metrics in line with expectations
Neckarsulm, 5 February 2025 – Based on preliminary figures, Bechtle AG has been able to reconcile its 2024 financial results with capital market expectations. Busine [ … ]
Wed, 05.02.2025
Swiss Prime Site Solutions
Swiss Prime Site Solutions
/ Key word(s): Capital Increase
Capital increase for Swiss Prime Site Solutions Investment Fund Commercial (SPSS IFC) in March 2025 05.02.2025 / 08:00 CET/CEST
Press Release
The SPSS IFC can look back on a successful 2023/2024 financial year (1.10.2023–30.9.2024). All strategic targets were met and s [ … ]
Wed, 05.02.2025
Gurit Holding AG
Gurit Holding AG
/ Key word(s): ESG
GURIT AWARDED ECOVADIS GOLD MEDAL FOR SUSTAINABILITY COMMITMENT AND PERFORMANCE
05.02.2025 / 06:45 CET/CEST
Zurich, February 5, 2025
Gurit (SIX Swiss Exchange: GURN) is pleased to announce that it has, for a second time, been awarded the Gold Medal by EcoVadis, a global leader in bus [ … ]
Wed, 05.02.2025
Formycon AG
Press Release // February 05, 2025
Lotus Pharmaceutical becomes strategic partner for the commercialization of Formycon’s Eylea® biosimilar FYB203/AHZANTIVE® in the Asia-Pacific Region
Planegg-Martinsried, Germany – Klinge Biopharma GmbH (“Klinge”), the exclusive owner of the global commercialization rights of FYB203/AHZANTIVE®1 (aflibercept [ … ]
Tue, 04.02.2025
SCHOTT Pharma AG & Co. KGaA
SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all agenda items
SCHOTT Pharma held its Annual General Meeting virtually on February 4, 2025
All items on the agenda were approved by shareholders
Dr. Wolfram Carius has been appointed to SCHOTT Pharma’s Supervisory Board, replacing Dr. Wolfgang Wienand
SCHOTT Pharma, [ … ]
Tue, 04.02.2025
Edison Investment Research Limited
London, UK, 4 February 2025
Edison issues report on Finsbury Growth & Income Trust (FGT)
Edison issues report on Finsbury Growth & Income Trust (LSE: FGT).
Finsbury Growth & Income Trust’s (FGT’s) portfolio has changed considerably since 2019. There is a greater exposure to digital winners, which now make up close to two-thirds [ … ]
Tue, 04.02.2025
Kudelski Group
Kudelski Group
/ Key word(s): Miscellaneous
The Kudelski Group announces transformation
and cost reductions
04.02.2025 / 17:40 CET/CEST
Ad hoc announcement pursuant to Art. 53 LR
Simplification of Group structure with a new focus on core digital security technologies
Kudelski Security will extend its expertise to O [ … ]
Tue, 04.02.2025
4finance S.A.
4finance EUR 2028 bond put option notification
4 February 2025. 4finance S.A. (“4finance” or the “Company”) notifies investors that it has published a put option notice in respect of its 11.25% EUR 2028 bonds, as per the Terms and Conditions amended in December 2023. Upon request from investors the Company may repurchase up to a total of EUR 15 [ … ]
Tue, 04.02.2025
Sun Tekstil
EQS-Media / 04.02.2025 / 15:17 CET/CEST
London, UK – Ekoten Tekstil, a subsidiary of Sun Tekstil, a leading force in textile manufacturing, is transforming production with artificial intelligence (AI)-powered defect detection, ensuring superior fabric quality while reinforcing its leadership in sustainability. The company’s real-time AI moni [ … ]
Tue, 04.02.2025
Laxxon Medical
Laxxon Medical Announces Positive Pilot PK Study Results for Advanced Levodopa/Carbidopa Asset for Parkinson’s Disease, LMX.5 New York, 02/04/2025 / 09:01, EST/EDT - EQS Newswire - Laxxon Medical
Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced drug delivery systems, today announced the p [ … ]
